Recombinant Activated Factor VII (rFVIIa) clinical trials

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial

This study is testing a new treatment for a type of stroke called 'intracerebral haemorrhage' (bleeding in the brain). Doctors want to see if giving a drug called rFVIIa soon after the stroke can reduce bleeding and improve recovery.